{"id":199773,"name":"PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION","slug":"pharma-biopharma-outsourcing-association","state":"NJ","country":"United States of America","description":"","totalSpending":1650000,"filings":33,"yearlySpending":[{"year":2018,"income":200000},{"year":2019,"income":200000},{"year":2020,"income":200000},{"year":2021,"income":200000},{"year":2022,"income":200000},{"year":2023,"income":200000},{"year":2024,"income":200000},{"year":2025,"income":250000}],"issues":["HCR","PHA","MAN","TAR"],"firms":["PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION"],"lobbyists":["GIL ROTH"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","White House Office","Bureau of Industry and Security (BIS)","Commerce, Dept of (DOC)","State, Dept of (DOS)"],"sampleDescriptions":["Lobbied for OTC Monograph Reform bill, answered questions about opioid manufacturing/packaging, discussed potential solutions to drug shortage situations, and provided general education about the phar","Lobbied for OTC Monograph Reform bill, answered questions about opioid manufacturing/packaging, discussed potential solutions to drug shortage situations, and provided general education about the phar","Lobbied for OTC Monograph Reform bill, answered questions about opioid manufacturing/packaging, discussed potential solutions to drug shortage situations, and provided general education about the phar","Lobbied for OTC Monograph Reform bill, answered questions about opioid manufacturing/packaging, discussed potential solutions to drug shortage situations, and provided general education about the phar","Lobbied for OTC Monograph Reform bill, answered questions about opioid manufacturing/packaging, discussed potential solutions to drug shortage situations, and provided general education about the phar"],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}